UK-based immunotherapy developer Scancell has begun research on a DNA-based COVID-19 vaccine. Read More

Many world leaders have signed on to the World Health Organization’s new initiative for COVID-19 research and development. Read More

Pharmacy benefit manager (PBM) reimbursements to pharmacies have failed to keep up with price increases for generic drugs, according to an analysis by 3 Axis Advisors, a consulting group that tracks drug supply-chain inefficiencies and pricing. Read More

The FDA warned Friday of potential heart rhythm problems from the use of hydroxychloroquine and chloroquine as COVID-19 treatments. Read More

Drugmakers, including Pfizer and Teva, are reporting shortages of azithromycin tablets, which are being used to treat COVID-19 patients. Read More

The agency wants to improve access to digital pathology devices during the public health emergency. Read More

AdaptVac hopes to begin a clinical trial by the end of the year. Read More

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is relaxing some GMP requirements to help manufacturers overcome challenges during the COVID-19 pandemic. Read More